Matches in Wikidata for { <http://www.wikidata.org/entity/Q85089116> ?p ?o ?g. }
Showing items 1 to 42 of
42
with 100 items per page.
- Q85089116 description "article scientifique publié en 2010" @default.
- Q85089116 description "artículu científicu espublizáu en xunetu de 2010" @default.
- Q85089116 description "im Juli 2010 veröffentlichter wissenschaftlicher Artikel" @default.
- Q85089116 description "scientific article published on 01 July 2010" @default.
- Q85089116 description "wetenschappelijk artikel" @default.
- Q85089116 description "наукова стаття, опублікована в липні 2010" @default.
- Q85089116 name "Switching to adalimumab is effective in a case of neuro-Behcet's disease refractory to infliximab" @default.
- Q85089116 name "Switching to adalimumab is effective in a case of neuro-Behcet's disease refractory to infliximab" @default.
- Q85089116 type Item @default.
- Q85089116 label "Switching to adalimumab is effective in a case of neuro-Behcet's disease refractory to infliximab" @default.
- Q85089116 label "Switching to adalimumab is effective in a case of neuro-Behcet's disease refractory to infliximab" @default.
- Q85089116 prefLabel "Switching to adalimumab is effective in a case of neuro-Behcet's disease refractory to infliximab" @default.
- Q85089116 prefLabel "Switching to adalimumab is effective in a case of neuro-Behcet's disease refractory to infliximab" @default.
- Q85089116 P1433 Q85089116-C21F193B-D704-47D9-9B0D-C8C438F52557 @default.
- Q85089116 P1476 Q85089116-81DEF62D-14C7-436B-B687-FD510DB8674B @default.
- Q85089116 P2093 Q85089116-1AD5CF21-1A73-4F23-97E0-3CF515A942A4 @default.
- Q85089116 P2093 Q85089116-2DAC1565-7AB7-4755-A6FB-AFD1B088D414 @default.
- Q85089116 P2093 Q85089116-4D75372B-9E35-4FF7-9CD9-54DB3F7BEBAE @default.
- Q85089116 P2093 Q85089116-5FA4C913-5EB9-41A5-8F01-8D00A1072764 @default.
- Q85089116 P2093 Q85089116-6091DFB6-38CA-4FDA-84A3-2D68591731EB @default.
- Q85089116 P304 Q85089116-243E0A42-6A0C-4BE1-B98C-8720E69A489D @default.
- Q85089116 P31 Q85089116-45DA6F0E-F29B-42CD-9811-029E1DBF46FF @default.
- Q85089116 P433 Q85089116-28F1AEF3-59A2-426A-AC91-FEB9439F2DE2 @default.
- Q85089116 P478 Q85089116-3D41CADE-028C-457C-BB77-CFBBBF09A5C8 @default.
- Q85089116 P577 Q85089116-31F9217D-A1B3-4EC2-9958-5E24B1DACA28 @default.
- Q85089116 P698 Q85089116-1913362E-F874-46B9-81C2-81A1049396EB @default.
- Q85089116 P921 Q85089116-BDBE3F52-040B-4A48-8867-233A16216112 @default.
- Q85089116 P698 20868587 @default.
- Q85089116 P1433 Q15759225 @default.
- Q85089116 P1476 "Switching to adalimumab is effective in a case of neuro-Behcet's disease refractory to infliximab" @default.
- Q85089116 P2093 "Gabriella Coniglio" @default.
- Q85089116 P2093 "Ignazio Olivieri" @default.
- Q85089116 P2093 "Padula Angela" @default.
- Q85089116 P2093 "Pietro Leccese" @default.
- Q85089116 P2093 "Salvatore D'Angelo" @default.
- Q85089116 P304 "S102" @default.
- Q85089116 P31 Q13442814 @default.
- Q85089116 P433 "4 Suppl 60" @default.
- Q85089116 P478 "28" @default.
- Q85089116 P577 "2010-07-01T00:00:00Z" @default.
- Q85089116 P698 "20868587" @default.
- Q85089116 P921 Q348260 @default.